leuprolidehttp://www.unboundmedicine.com/medline/ebm/research/leuprolideUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Effectiveness of the Combined Recombinant Human Growth Hormone and Gonadotropin-Releasing Hormone Analog Therapy in Pubertal Patients with Short Stature due to SHOX Deficiency.http://www.unboundmedicine.com/medline/ebm/record/19926713/full_citation/Effectiveness_of_the_Combined_Recombinant_Human_Growth_Hormone_and_Gonadotropin_Releasing_Hormone_Analog_Therapy_in_Pubertal_Patients_with_Short_Stature_due_to_SHOX_Deficiency_Scalco RC, Melo SS, Pugliese-Pires PN, et al. 
Effectiveness of the Combined Recombinant Human Growth Hormone and Gonadotropin-Releasing Hormone Analog Therapy in Pubertal Patients with Short Stature due to SHOX Deficiency. [JOURNAL ARTICLE]
J Clin Endocrinol Metab 2009 Nov 19.
Abstract | Full Citation | Find Related Articles Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty.http://www.unboundmedicine.com/medline/ebm/record/19920916/full_citation/Experience_with_the_once_yearly_histrelin__GnRHa__subcutaneous_implant_in_the_treatment_of_central_precocious_puberty_Lewis KA, Eugster EA 
Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:1-5.
Abstract | Full Citation | Find Related Articles Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study.http://www.unboundmedicine.com/medline/ebm/record/19912212/full_citation/Changes_in_alkaline_phosphatase_levels_in_patients_with_prostate_cancer_receiving_degarelix_or_leuprolide:_results_from_a_12_month_comparative_phase_III_study_Schröder FH, Tombal B, Miller K, et al. 
Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study. [JOURNAL ARTICLE]
BJU Int 2009 Nov 13.
Abstract | Full Citation | Find Related Articles Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study.http://www.unboundmedicine.com/medline/ebm/record/19909586/full_citation/Single_dose_GnRH_agonist_administration_in_the_luteal_phase_of_GnRH_antagonist_cycles:_a_prospective_randomized_study_Isik AZ, Caglar GS, Sozen E, et al. 
Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study. [Journal Article]
Reprod Biomed Online 2009 Oct; 19(4):472-7.
Abstract | Full Citation | Find Related Articles Immunosuppressive CD14(+)HLA-DR(low/-) monocytes in prostate cancer.http://www.unboundmedicine.com/medline/ebm/record/19902470/full_citation/Immunosuppressive_CD14_+_HLA_DR_low/___monocytes_in_prostate_cancer_Vuk-Pavlović S, Bulur PA, Lin Y, et al. 
Immunosuppressive CD14(+)HLA-DR(low/-) monocytes in prostate cancer. [JOURNAL ARTICLE]
Prostate 2009 Nov 9.
Abstract | Full CitationHigher leuprolide dose does not diminish the ovarian response to gonadotropins in a protocol using pre-treatment with oral contraceptives.http://www.unboundmedicine.com/medline/ebm/record/19892344/full_citation/Higher_leuprolide_dose_does_not_diminish_the_ovarian_response_to_gonadotropins_in_a_protocol_using_pre_treatment_with_oral_contraceptives_Hurst BS, Hurst KM, Matthews ML 
Higher leuprolide dose does not diminish the ovarian response to gonadotropins in a protocol using pre-treatment with oral contraceptives. [JOURNAL ARTICLE]
Int J Gynaecol Obstet 2009 Nov 3.
Full Citation | Find Related Articles Leuprolide acetate gonadotropin response patterns during female puberty.http://www.unboundmedicine.com/medline/ebm/record/19863573/full_citation/Leuprolide_acetate_gonadotropin_response_patterns_during_female_puberty_Martinez-Aguayo A, Hernández MI, Capurro T, et al. 
Leuprolide acetate gonadotropin response patterns during female puberty. [JOURNAL ARTICLE]
Clin Endocrinol (Oxf) 2009 Oct 26.
Abstract | Full Citation | Find Related Articles Pre- Versus Postmenopausal Age, Estradiol, and Peptide-Secretagogue Type Determine Pulsatile Growth Hormone Secretion in Healthy Women: Studies Using Submaximal Agonist Drive and an Estrogen Clamp.http://www.unboundmedicine.com/medline/ebm/record/19858315/full_citation/Pre__Versus_Postmenopausal_Age_Estradiol_and_Peptide_Secretagogue_Type_Determine_Pulsatile_Growth_Hormone_Secretion_in_Healthy_Women:_Studies_Using_Submaximal_Agonist_Drive_and_an_Estrogen_Clamp_Hudson SB, Schroeder DR, Bailey JN, et al. 
Pre- Versus Postmenopausal Age, Estradiol, and Peptide-Secretagogue Type Determine Pulsatile Growth Hormone Secretion in Healthy Women: Studies Using Submaximal Agonist Drive and an Estrogen Clamp. [JOURNAL ARTICLE]
J Clin Endocrinol Metab 2009 Oct 26.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer.http://www.unboundmedicine.com/medline/ebm/record/19842040/full_citation/Apoplexy_in_non_functioning_pituitary_adenoma_after_one_dose_of_leuprolide_as_treatment_for_prostate_cancer_Guerra Y, Lacuesta E, Marquez F, et al. 
Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer. [JOURNAL ARTICLE]
Pituitary 2009 Oct 20.
Abstract | Full CitationA rare case of central precocious puberty due to hypothalamic hamartoma diagnosed in utero.http://www.unboundmedicine.com/medline/ebm/record/19789152/full_citation/A_rare_case_of_central_precocious_puberty_due_to_hypothalamic_hamartoma_diagnosed_in_utero_Acharya SV, Gopal RA, Menon PS, et al. 
A rare case of central precocious puberty due to hypothalamic hamartoma diagnosed in utero. [JOURNAL ARTICLE]
Endocr Pract 2009 Sep 28.:1-11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles